As of 2025-10-08, the EV/EBITDA ratio of Elliptic Laboratories AS (ELABS.OL) is 50.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ELABS.OL's latest enterprise value is 924.35 mil NOK. ELABS.OL's TTM EBITDA according to its financial statements is 18.31 mil NOK. Dividing these 2 quantities gives us the above ELABS.OL EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 18.3x | 16.0x |
| Forward P/E multiples | 10.8x - 16.7x | 12.8x |
| Fair Price | 2.59 - 7.28 | 4.41 |
| Upside | -71.7% - -20.5% | -51.8% |
| Date | EV/EBITDA |
| 2025-10-03 | 51.28 |
| 2025-10-02 | 50.65 |
| 2025-10-01 | 51.05 |
| 2025-09-30 | 51.11 |
| 2025-09-29 | 52.26 |
| 2025-09-26 | 51.86 |
| 2025-09-25 | 51.28 |
| 2025-09-24 | 51.80 |
| 2025-09-23 | 53.76 |
| 2025-09-22 | 52.15 |
| 2025-09-19 | 52.03 |
| 2025-09-18 | 52.43 |
| 2025-09-17 | 53.99 |
| 2025-09-16 | 54.04 |
| 2025-09-15 | 55.31 |
| 2025-09-12 | 55.88 |
| 2025-09-11 | 56.80 |
| 2025-09-10 | 57.61 |
| 2025-09-09 | 58.99 |
| 2025-09-08 | 57.61 |
| 2025-09-05 | 58.99 |
| 2025-09-04 | 56.92 |
| 2025-09-03 | 55.31 |
| 2025-09-02 | 55.54 |
| 2025-09-01 | 55.77 |
| 2025-08-29 | 56.80 |
| 2025-08-28 | 63.93 |
| 2025-08-27 | 67.73 |
| 2025-08-26 | 64.97 |
| 2025-08-25 | 66.81 |
| 2025-08-22 | 61.40 |
| 2025-08-21 | 63.13 |
| 2025-08-20 | 66.23 |
| 2025-08-19 | 68.19 |
| 2025-08-18 | 66.81 |
| 2025-08-15 | 68.99 |
| 2025-08-14 | 69.11 |
| 2025-08-13 | 68.53 |
| 2025-08-12 | 67.27 |
| 2025-08-11 | 66.92 |
| 2025-08-08 | 68.53 |
| 2025-08-07 | 68.19 |
| 2025-08-06 | 66.35 |
| 2025-08-05 | 67.38 |
| 2025-08-04 | 66.00 |
| 2025-08-01 | 67.27 |
| 2025-07-31 | 69.22 |
| 2025-07-30 | 69.34 |
| 2025-07-29 | 70.60 |
| 2025-07-28 | 73.25 |